EZRA PERLMAN

Since joining the firm in 2003, Ezra founded and co-leads FP’s HCIT practice, which is currently recognized as one of the most successful HCIT practices in the industry. Ezra has played a critical leadership role in an array of transactions, including some of FP’s most complex carve-outs and strategic acquisitions. Ezra has helped drive some of FP’s most successful exits, including the sales of CoverMyMeds, eSolutions, Landmark, myON and Quadramed. In the past year, Ezra co-led the firm’s efforts in the carve-out of Watson Health from IBM, which was later rebranded into a standalone company, Merative. He also played a key leadership role in FP’s carve-out acquisition of bswift from CVS Health. He serves on the board of directors of Avalon, bswift, Edifecs, Merative, QGenda and Renaissance. Ezra has an AB in applied mathematics from Harvard College as well as an MBA from Stanford GSB.